Massive survey aims to map haemophilia in Asia-Pacific

NCT ID NCT07163260

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects information from doctors and patient groups across Asia and the Pacific to better understand how haemophilia affects people in the region. No treatments or medications are given; instead, researchers will analyze data on how many people have the condition, how often new cases occur, and what care is currently available. The goal is to improve future care and support for people with haemophilia.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemophilia hemophilia A hemophilia B

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HAEMOPHILIA

Contacts and locations

Show contact details

Locations

Novo Nordisk Investigational Site

Bangalore, Karnataka, 560 066, India
Novo Nordisk Investigational Site

Kuala Lumpur, 50470, Malaysia
Novo Nordisk Investigational Site

Seoul, South Korea
Novo Nordisk Investigational Site

Bangkok, 10500, Thailand